Athanor Capital, LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 263 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Athanor Capital, LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2021$704,000
-5.1%
7,237
+9.4%
0.02%
-5.9%
Q4 2020$742,000
-10.1%
6,613
-35.8%
0.02%
-55.3%
Q4 2019$825,000
+65.0%
10,300
+51.5%
0.04%
+18.8%
Q3 2019$500,000
+4.0%
6,800
+33.3%
0.03%
-48.4%
Q2 2019$481,0005,1000.06%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders